RLAY Next Earnings Date Notes

— Relay Therapeutics (RLAY) is a biotechnology company leveraging a unique platform that integrates computational & experimental techniques to design precision medicines, particularly targeting protein motion (dynamics) in drug discovery. Relay's focus is on developing small molecule therapies for cancers & genetic diseases, using insights derived from their Dynamo platform to address previously intractable targets. For investors following RLAY's upcoming earnings call, the most relevant business metrics include clinical trial progress (especially updates on lead candidates like rylatlimab, lirafugratinib, & other pipeline assets), partnership revenues, cash runway, R&D expenses, and guidance updates relating to future pivotal trial milestones or regulatory submissions. Equally important are any developments regarding strategic collaborations, licensing deals, or partnerships that might accelerate clinical development or provide non-dilutive funding. Monitoring patient enrollment rates & safety/efficacy readouts in ongoing trials, as well as management commentary on competitive positioning and near-term catalysts, will provide key indicators of Relay's long-term success. By tracking these fundamentals, investors can gain the clearest view of RLAY's progress and its path toward commercializing transformative therapies. The next projected earnings date for RLAY is 8/6/2026 after close (stay tuned for a confirmed earnings date once announced).

RLAY Next Earnings Date FAQ

On this page we presented the RLAY Next Earnings Date information for Relay Therapeutics along with recent past earnings dates. For Q1 of 2026, RLAY reported earnings of -0.410/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, RLAY reported earnings of -0.320/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, RLAY reported earnings of -0.430/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, RLAY reported earnings of -0.410/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, RLAY reported earnings of -0.460/share, with the earnings report taking place on 5/5/2025. Based on these past earnings dates, the projected next earnings date for RLAY is 8/6/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Relay Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Relay Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Relay Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next RLAY earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up RLAY's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the RLAY next earnings date.